Editorial: 5-aminosalicylic acid fails to impact on irritable bowel syndrome-wrong population, intervention, target or hypothesis? Quigley EMM. Aliment Pharmacol Ther 2022;56:1497-1498.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Quigley EMM. Editorial: 5-aminosalicylic acid fails to impact on irritable bowel syndrome-wrong population, intervention, target or hypothesis? Aliment Pharmacol Ther 2022;56:1497-1498.
PMID: 36271475